Who invested in EpilepsyGTx

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechGenomics

Raised 10 months ago

Funding summaryUpdated 26 Oct 2026

$33Mraised across 1 round since 2025, from 1 source

Latest round: Series A, $33MDec 2025
Investors: 2

See who backed them

The rounds

Dec 2025
Series A$33M
- British Business Bank
- XGEN Venture
Reported by UCL Technology Fund

Funding filed with regulators

EpilepsyGTx filed 4 raises, $26M in all. Filings say how much was sold and to how many investors; they never name the investors.

Mar 2026$4.2MUK share allotment
Dec 2025$19MUK share allotment
Dec 2023$1.9MUK share allotment
May 2023$1.3MUK share allotment

Founders and team

From EpilepsyGTx's own website: 3 founders, 6 on the team.

Professor Dimitri KullmannChief Scientific Officer and Scientific Founder

Professor Gabriele LignaniProfessor of Translational Neuroscience (UCL) and Scientific Founder

Professor Stephanie SchorgeProfessor of Neuroscience (UCL) and Scientific Founder

Nicolas KoebelChief Executive Officer
Dr Teresa NunesChief Medical Officer
Dr Bernard RavinaIndependent Director
Dr Caitriona O’RourkeDirector
Dr Jan ThirkettleBoard Chair (interim)
Dr Luiz Almeida SilvaResearch Director

Everyone who backed them

British Business BankCorporate VC1round

XGEN VentureVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about EpilepsyGTx